CreatorsPublishersAdvertisers

#College Of Medicine

elizabethton.com

The Quillen 100 will benefit Speedway Children’s Charities

Cyclists of all experience levels will race the World’s Fastest Half-Mile this fall as a full day of relay events roll onto the track at Bristol Motor Speedway (BMS), Saturday, Oct. 16, for The Quillen 100. Started in 2019 by students in the East Tennessee State University Quillen College of...
CHARITIES
Picture for The Quillen 100 will benefit Speedway Children’s Charities
fsu.edu

FSU expands program to spark interdisciplinary research

A Florida State University program to support interdisciplinary research teams is getting an upgrade. The FSU Office of Research Development’s Collaborative Collision program started in 2016 to offer faculty a way to meet others at FSU who might share their research interests. Now, it’s expanding to become “Collaborative Collision 2.0” and offer more support to faculty developing interdisciplinary teams. The program, which addresses a different societal problem in each event, will take place over three stages: Connector, Incubator, and Accelerator.
FLORIDA STATE
Picture for FSU expands program to spark interdisciplinary research
uthsc.edu

College of Medicine Sows Seeds of Health in New Frayser Community Garden

Ernest J. Trice, a volunteer urban gardener, stood at the edge of several plowed rows in a field in Frayser Wednesday afternoon explaining the finer points of sowing seeds to those who gathered for the fall planting kick-off of the Frayser Community Garden, a new outreach effort of the College of Medicine at the University of Tennessee Health Science Center.
MEMPHIS, TN
Picture for College of Medicine Sows Seeds of Health in New Frayser Community Garden
TRENDING TOPICS
IFLScience

Mechanism Behind Long COVID May Have Been Discovered

Researchers may have discovered an underlying mechanism resulting in long COVID, the lingering condition following COVID-19 that leaves some people with brain fog, respiratory problems, and more. The research, published in The Public Library of Science ONE (PLOS ONE), hints at the production of an auto-antibody weeks after infection that disrupts the regulation of the immune system, resulting in the overactivation of immune proteins and inflammation.
MEDICAL SCIENCE
ScienceBlog.com

Ebola vaccine regimen generates strong immune response in children and adults

Johnson & Johnson’s two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases. The EBOVAC-Salone study provides important further evidence for the potential of the regimen using the...
SCIENCE
rdworldonline.com

UAMS research team finds potential cause of COVID-19 ‘long-haulers’

A University of Arkansas for Medical Sciences (UAMS) research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE). At the heart of the team’s findings is...
PUBLIC HEALTH
osu.edu

$7.8 million federal award funds Alzheimer's research resource network

COLUMBUS, Ohio – The National Institute on Aging has awarded funding to build an interdisciplinary resource network for Alzheimer’s disease (AD) and AD-related dementias. The award, which is expected to total $7.8 million over five years, brings together The Ohio State University Wexner Medical Center and College of Medicine researchers with clinical scientists in the Pathology Department of the University of Washington, neuroscientists in the Mitchell Center for Neurodegenerative Diseases at the University of Texas Medical Branch and structural biologists at University of California, Los Angeles.
COLUMBUS, OH
pennstatehealthnews.org

College of Medicine researchers named finalists in technology commercialization program

Two technologies developed by Penn State College of Medicine researchers have advanced to the final round of a program that seeks to develop life science research and development projects with high potential for improving human health. One is a new small molecule that could be used to treat an aggressive form of breast cancer. The second technology is a device that may help plastic surgeons better perform procedures.
CANCER
buzinessbytes.com

J&J’s two-dose Ebola vax regimen safe: Study

London, Sep 15 (IANS) The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases. The study provides important...
PHARMACEUTICALS
islandfm.com

High hopes for Ebola vaccine after trial shows strong immune response

Children and adults have shown a strong immune response to a possible Ebola vaccine during clinical trials in Sierra Leone. The two-dose vaccine from Johnson & Johnson was also found to be safe and well tolerated, according to research published in The Lancet Infectious Diseases. The EBOVAC-Salone study is the...
PHARMACEUTICALS
YOU MAY ALSO LIKE